Sharemaestro Newsreel

Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages

Alvotech (NASDAQ:ALVO) has received a consensus "Hold" rating from six brokerages, with an average 12-month price target of $7.60, significantly higher than its current share price of $3.53. Institutional investors like ProShare Advisors and Mirae Asset Global Investments have increased their stakes, while the …

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. The company will also host a conference call at 2:00 p.m. Pacific Time on the same day to discuss these results. Investors …

Haleon plc Non-GAAP EPS of 10.30p, revenue of £5.6B; reaffirms FY outlook

* Haleon plc press release [https://www.haleon.com/news/press-releases/financial/2026/2026-half-year-results] (HLN [https://seekingalpha.com/symbol/HLN]): 1H Non-GAAP EPS of 10.30p. * Revenue of £5.6B, up 2.2% Y/Y. * Free cash flow: H1 £769m, up £35m supported by strong operating leverage * Net debt/Adjusted EBITDA: 2.5x at end of H1, in line …

InMed Pharmaceuticals Inc (INM) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of InMed Pharmaceuticals Inc (INM), ranking it 190 out of 384 in the Biotechnology & Medical Research industry with a current financial score of 6.87. It notes the company's robust financial status but low operating efficiency. The report …

LQDA|Liquidia Corp|Price:86.870|Chg%:+0.050

This article provides a detailed financial overview of Liquidia Corp (LQDA), including its stock performance, key financial indicators like EPS, revenue, net profit, and gross margin across various quarters and fiscal years. It also presents the company's balance sheet and cash flow statement data, …

First Trust Advisors LP Grows Stock Holdings in Perrigo Company plc $PRGO

First Trust Advisors LP significantly increased its stake in Perrigo Company plc (NYSE:PRGO) by acquiring an additional 832,686 shares, bringing its total holdings to 1.50 million shares valued at approximately $16.1 million. Despite this, analyst sentiment remains cautious with a consensus "Hold" rating and …

Amneal Pharmaceuticals (AMRX) Wins FDA Nod For Iohexol, Is The Upside Already Priced In?

Amneal Pharmaceuticals (AMRX) recently received FDA approval for additional strengths and vial sizes of its iohexol injection, boosting its product portfolio and contributing to strong share price momentum. While analysts consider the stock about 5% overvalued with a fair value of $18.25, Simply Wall …

Bausch Health Companies Inc (BHC) - Tradingkey

This article provides a comprehensive stock analysis of Bausch Health Companies Inc (BHC) by Tradingkey. It highlights the company's stable fundamentals, high growth potential, and current "Hold" rating from analysts with an upside space targeting 7.17. Despite high institutional ownership and a recent shift …

BIOAGE Labs Inc (BIOA) Institutional Confidence

The article details the institutional confidence score for BIOAGE Labs Inc (BIOA), which is currently 5.00, placing it 132nd in the Biotechnology & Medical Research industry. Institutional shareholding stands at 65.54%, marking a 24.58% decrease quarter-over-quarter. Key institutional shareholders and their share movements are …

Aurora Cannabis Inc (ACB) Institutional Confidence

This article from TradingKey focuses on the institutional confidence score for Aurora Cannabis Inc (ACB), which currently stands at 3.00. It details the institutional shareholdings and recent activity of major investment firms in ACB, noting significant changes in their positions. The information includes the …

Cronos Group (CRON) Expected to Announce Earnings on Thursday

Cronos Group (CRON) is expected to announce its Q2 2026 earnings before market open on Thursday, August 6th, with analysts forecasting earnings of $0.01 per share and revenue of $44.20 million. The company reported meeting its consensus earnings estimate in its last quarter, with …

Dr. Reddy’s Sees Weight-Loss Drug Boosting Growth After Setback

Dr. Reddy’s Laboratories Ltd. anticipates a significant growth boost in the December and March quarters, following resolution of an impurity issue with its generic anti-obesity drug, semaglutide. The company expects to resume supply in early November, mitigating the impact of the issue on its …

Haleon Raises Interim Dividend Following First-Half 2026 Results

Haleon plc has announced a 9% increase in its interim dividend for the first half of 2026, setting it at 2.4 pence per ordinary share. The company reaffirmed its policy of growing dividends in line with adjusted earnings and expressed a positive outlook for …

Xeris Biopharma Holdings Inc (XERS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Xeris Biopharma Holdings Inc (XERS), noting its current valuation score of 8.01 within the Pharmaceuticals industry. It highlights the company's P/E ratio of 104.89, which is significantly below its recent high but above its recent low. Key …

Amphastar Pharmaceuticals Inc (AMPH) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Amphastar Pharmaceuticals Inc (AMPH)'s financial health, indicating a stable financial status and high operating efficiency with a current score of 8.70. The company reported a significant year-over-year increase in net profit by 74.61%, despite a modest revenue increase …

Prestige Consumer Healthcare Inc (PBH) Institutional Confidence

Prestige Consumer Healthcare Inc (PBH) has a strong institutional confidence score of 10.00, placing it first in the Pharmaceuticals industry. The institutional shareholding proportion has increased to 121.63%, with John Rogers being the largest institutional shareholder. Several major institutional investors hold significant shares, with …

Amylyx Pharmaceuticals Inc (AMLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Amylyx Pharmaceuticals Inc (AMLX), covering its current price momentum score, support and resistance levels, and various technical indicators. It details the readings for MACD, RSI, KDJ, ATR, CCI, Williams %R, TRIX, and StochRSI, along with moving averages …

ANIP|ANI Pharmaceuticals Inc|Price:81.750|Chg%:+0.710

This article provides a detailed financial overview of ANI Pharmaceuticals Inc (ANIP), presenting its income statement, balance sheet, and cash flow statement. It highlights key financial indicators such as EPS, Revenue, Net Profit, and various margins, alongside projected earnings and revenue forecasts. The document …

What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders

Viatris (VTRS) recently received FDA approval for Gwyn Lo, a new weekly low-estrogen contraceptive patch, which is expected to diversify its product mix towards higher-margin, branded offerings. This approval supports the company's strategy to shift from a generics-heavy portfolio to more complex and branded …

Takeda Pharmaceutical Co cuts FY26 adj EPS to $2.96, sales to $29.1B

Kamada Ltd. (KMDA) Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Reaction - Earnings Preview

The Goldman Sachs Group Issues Positive Forecast for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price

Organogenesis (ORGO) to Release Quarterly Earnings on Thursday

Collegium Pharmaceutical (COLL) Expected to Post Earnings on Thursday

Amneal Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AMRX) 2026-07-30

Image source: The Motley Fool. DATE Thursday, July 30, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Anthony DiMeoCo-Founder and Co-Chief Executive Officer - Chirag PatelCo-Founder and Co-Chief Executive Officer - Chintu PatelChief Financial Officer - Anastasios KonidarisSpecialty - Joe …

Amneal Debt Repricing Expected to Save About $12M a Year

Wells Fargo Gives a Buy Rating to Alkermes (ALKS)

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth

Haleon (LON:HLN) Releases Earnings Results

Haleon Sees Volume Recovery From North America, and Margins Continue to Improve

Haleon, one of the leading consumer healthcare companies globally, is experiencing a recovery in volume from North America, with margins showing continuous improvement. The company has streamlined its operations by divesting non-strategic brands and optimizing its manufacturing and distribution networks. This strategic optimization positions …

Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat

By Raechel Thankam Job and Richa Naidu July 30 (Reuters) - Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can ‌meet its sales targets, sending shares in the consumer health company lower despite ‌better-than-expected first-half profit. The British …

Is United Therapeutics (UTHR) Undervalued After Its Phase 3 Ralinepag Results?

Kiniksa Pharmaceuticals (KNSA) Stock Cools As Raised Guidance Meets ARCALYST Reliance

Akebia Therapeutics (AKBA) to Announce Earnings on Thursday

Akebia Therapeutics (AKBA) is scheduled to announce its Q2 2026 earnings before market open on Thursday, August 6th, with analysts expecting a loss of ($0.03) per share and revenue of $48.8520 million. The bi

Alvotech Shares Rise After Wrapping FDA Facility Inspection

Alvotech's shares increased following the successful completion of a U.S. FDA facility inspection related to its a new biosimilar project, AVT02. The company received some observations but stated they are not expected to impact the timeline for its Humira biosimilar. This marks a significant …

Evolus Inc (EOLS) Financial Health: Profitability & Balance Sheet Analysis

The financial score for Evolus Inc (EOLS) is 8.00, placing it 82nd out of 155 in the Pharmaceuticals industry, indicating a weak financial status but high operating efficiency. The company reported a 6.74% year-over-year increase in its latest quarterly revenue to $73.14M and a …